SecBot SecBot
144 ·Filed May 15, 2026

TVTX

Travere Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed6mo ago SEC0001376043-26-000004
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine director sale with no material signal. Monitor for any subsequent Form 4 filings to confirm execution, but no trading action warranted.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$42.59
T+0 close · May 15, 2026 · via day close
Latest settled
+41.37%
T+60 · $60.21
Vs SPY
+36.86%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 15 $42.59entry
  2. T+1 · 6mo ago +0.70%α +0.77% · $42.89
  3. T+5 · 6mo ago +4.32%α +3.36% · $44.43
  4. T+20 · 5mo ago +26.32%α +24.20% · $53.80
  5. T+60 · 3mo ago +41.37%α +36.86% · $60.21
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Timothy Coughlin filed a Form 144 notice to sell 3,250 shares of Travere Therapeutics (TVTX) valued at approximately $141,183. The sale represents a small portion of his holdings and is routine for a director. No material impact expected.

Key Facts

  • Director Timothy Coughlin filed Form 144 to sell 3,250 shares of TVTX
  • Estimated sale value: $141,182.59
  • Shares acquired via restricted stock awards on 11/18/2025
  • Sale intended for 05/15/2026 on Nasdaq
  • Broker: Wells Fargo Clearing Services

Financial Impact

Sale of 3,250 shares valued at ~$141K, representing a small fraction of director's holdings and <0.01% of TVTX's $4.1B market cap

insider holdings

Risk Factors

  • Insider selling pattern could emerge if additional directors file similar notices
  • Form 144 is intent to sell; sale may not be executed

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001376043-26-000004
Document: 0001376043-26-000004-index.html0001376043-26-000004
Document: 0001376043-26-000004.txt0001376043-26-000004

Track record

21 reports on TVTX

Performance horizon

8 of 10 bullish or bearish reports moved the stock their way by T+5. Best: +56.24% at T+60 after the Jun 2, 2026 report. 10 of 10 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $50.30 Now $49.70 −1.19% settles Nov 23
  2. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $48.87 to $51.56 Now $49.70 +1.70% ▲ +5.50% +2.21% vs SPY
  3. Nov 3, 202613d ago Institutional Cluster Bullish 4/10 Entry $49.41 to $51.99 Now $49.70 +0.59% ▲ +5.22% +5.81% vs SPY
  4. Nov 2, 202614d ago 8-K Bullish 6/10 Entry $49.41 to $51.99 Now $49.70 +0.59% ▲ +5.22% +5.81% vs SPY
  5. Sep 17, 20268w ago Insider Cluster Bearish 4/10 Entry $62.76 to $59.44 Now $49.70 +20.81% ▲ +5.29% +6.56% vs SPY
  6. Jul 9, 202618w ago 8-K Neutral 2/10 Entry $56.59 to $55.28 Now $49.70 −12.18% ▼ −2.31% −1.75% vs SPY
  7. Jun 16, 202621w ago Insider Cluster Neutral 2/10 Entry $54.14 to $57.69 Now $49.70 −8.20% ▲ +6.56% +7.60% vs SPY
  8. Jun 16, 202621w ago 8-K Neutral 2/10 Entry $54.14 to $57.69 Now $49.70 −8.20% ▲ +6.56% +7.60% vs SPY
  9. Jun 12, 202622w ago 144 Neutral 2/10 Entry $52.04 to $55.15 Now $49.70 −4.50% ▲ +5.98% +5.30% vs SPY
  10. Jun 2, 202623w ago 8-K Bullish 6/10 Entry $42.96 to $48.57 Now $49.70 +15.69% ▲ +13.06% +16.02% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 7h 32m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 15, 2026